Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

[A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand].

Luo ZR, Zheng WX, Huang MF, Chen H, Wang ZQ.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Nov;25(11):673-6. doi: 10.3760/cma.j.issn.2095-4352.2013.11.009. Chinese.

2.

[Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease].

Xu DR, Su C, Zou WY, Xu HR, Huang S, Li J, Luo SK.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):376-80. Chinese.

PMID:
20416172
3.

Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome.

Ren MY, Sui SJ, Zhang Y, Xu FY, Xu XQ, Zhao JJ, Du YM, Liu WH.

Acta Cardiol. 2008 Oct;63(5):615-22.

4.

[Expert survey for Chinese medicine syndrome characteristics of different clinical types of coronary artery disease based on the Delphi method].

Bi YF, Mao JY, Wang XL, Li B, Hou YZ, Zhao ZQ, Ge YB, Zhao GF.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Oct;34(10):1192-6. Chinese.

PMID:
25509260
5.

The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris.

Aksu F, Ozçelik F, Kunduracilar H, Barutçu A, Yel M, Umit EG, Altun A.

Kardiol Pol. 2014;72(1):34-41. doi: 10.5603/KP.2014.0004.

6.

Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention.

Liu HY, Wang W, Shi DZ, Ge JB, Zhang L, Peng J, Wang CL, Wang PL.

Chin J Integr Med. 2012 Jun;18(6):423-30. doi: 10.1007/s11655-012-0966-5. Epub 2012 Feb 29.

PMID:
22382523
7.

Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.

Palazzuoli A, Rizzello V, Calabrò A, Gallotta M, Martini G, Quatrini I, Campagna MS, Franci B, Nuti R.

Clin Chim Acta. 2008 May;391(1-2):74-9. doi: 10.1016/j.cca.2008.02.008. Epub 2008 Feb 15.

PMID:
18328262
8.

[Characteristics of traditional Chinese medicine syndromes in patients with acute ischemic stroke of yin or yang syndrome: a multicenter trial].

You JS, Huang Y, Cai YF, Guo JW, Liang WX, Huang PX, Liu MC.

Zhong Xi Yi Jie He Xue Bao. 2008 Apr;6(4):346-51. doi: 10.3736/jcim20080404. Chinese.

9.

[Relationship between Chinese medicine syndrome and peripheral blood stem cells in patients with ischemic heart failure].

Zhou YP, Hu YH, Wu HQ.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Sep;29(9):798-801. Chinese.

PMID:
19960976
10.

Study on syndrome element characteristics and its correlation with coronary angiography in 324 patients with coronary heart disease.

WANG J, CHU FY, LI J, YAO KW, ZHONG JB, ZHOU KH, HE QY, SUN XW.

Chin J Integr Med. 2008 Dec;14(4):274-80. doi: 10.1007/s11655-008-0274-2. Epub 2008 Dec 12.

PMID:
19082799
11.

[Relationship between coronary angiography and syndrome differentiation type of TCM].

Ma XC, Yin TY, Chen KJ.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 Sep;21(9):654-6. Chinese.

PMID:
12575549
12.

[Dynamic changes in traditional Chinese medicine syndromes in patients with ischemic stroke treated by acupuncture].

Song Y, Pei J, Liu ZD, Li HY, Cai YF, Guo JW, Huang Y.

Zhong Xi Yi Jie He Xue Bao. 2009 Apr;7(4):334-41. doi: 10.3736/jcim20090407. Chinese.

13.

Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis.

Dovio A, Data V, Carignola R, Calzolari G, Vitetta R, Ventura M, Saba L, Severino A, Angeli A.

J Rheumatol. 2008 Nov;35(11):2206-13. Epub 2008 Oct 1.

PMID:
18843778
14.

Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.

Carmona-Fernandes D, Santos MJ, Perpétuo IP, Fonseca JE, Canhão H.

Arthritis Res Ther. 2011;13(5):R175. doi: 10.1186/ar3500. Epub 2011 Oct 25.

15.
16.

Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.

Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.

Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22.

PMID:
19158438
18.

Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women.

Hofbauer LC, Schoppet M, Schüller P, Viereck V, Christ M.

Clin Endocrinol (Oxf). 2004 Feb;60(2):214-9.

PMID:
14725683
19.

Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.

Palazzuoli A, Ascione R, Gallotta M, Calabrò A, Gonnelli S, Quatrini I, Campagna MS, Franci B, Nuti R.

Int J Cardiol. 2009 Nov 12;137(3):295-8. doi: 10.1016/j.ijcard.2008.05.048. Epub 2008 Aug 15.

PMID:
18707771
20.

Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.

Kraj M, Owczarska K, Sokołowska U, Centkowski P, Pogłód R, Kruk B.

Arch Immunol Ther Exp (Warsz). 2005 Sep-Oct;53(5):454-64.

PMID:
16314829
Items per page

Supplemental Content

Write to the Help Desk